The majority of our system users have come from those who have type one or type two diabetes. About 50% of people in that category in the US use continuous glucose monitoring. Recently, CMS expanded CGM coverage for those who take any insulin. And that should double the size of that addressable market in the US ultimately to about seven and eight million individuals.
Data this week suggest India is about to pass China as the world's most populous country. (0:25) Bill Mann discusses: - Procter & Gamble bumping up against the limits of its pricing powers - Why China still has a demand problem - How companies in the U.S. are moving some operations from China to Vietnam and India (11:25) Sanmeet Deo talks with Dexcom CEO Kevin Sayer about his company's work in continuous glucose monitors and a major shift affecting the future of healthcare.
Stocks discussed: PG, CMG, AAPL, SBUX, DXCM Host: Chris Hill Guest: Bill Mann, Sanmeet Deo, Kevin Sayer Producer: Ricky Mulvey Engineers: Rick Engdahl, Tim Sparks
Learn more about your ad choices. Visit megaphone.fm/adchoices